JP2019513138A5 - - Google Patents

Download PDF

Info

Publication number
JP2019513138A5
JP2019513138A5 JP2018550558A JP2018550558A JP2019513138A5 JP 2019513138 A5 JP2019513138 A5 JP 2019513138A5 JP 2018550558 A JP2018550558 A JP 2018550558A JP 2018550558 A JP2018550558 A JP 2018550558A JP 2019513138 A5 JP2019513138 A5 JP 2019513138A5
Authority
JP
Japan
Prior art keywords
concentration
potassium
phosphorus
mannitol
serum albumin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2018550558A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019513138A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/024365 external-priority patent/WO2017172643A1/en
Publication of JP2019513138A publication Critical patent/JP2019513138A/ja
Publication of JP2019513138A5 publication Critical patent/JP2019513138A5/ja
Withdrawn legal-status Critical Current

Links

JP2018550558A 2016-03-31 2017-03-27 改良された製剤によりアルファウイルスを安定化するための組成物及び方法 Withdrawn JP2019513138A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662316262P 2016-03-31 2016-03-31
US62/316,262 2016-03-31
PCT/US2017/024365 WO2017172643A1 (en) 2016-03-31 2017-03-27 Compositions and methods for stabilizing alphaviruses with improved formulations

Publications (2)

Publication Number Publication Date
JP2019513138A JP2019513138A (ja) 2019-05-23
JP2019513138A5 true JP2019513138A5 (enExample) 2020-07-09

Family

ID=58537071

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018550558A Withdrawn JP2019513138A (ja) 2016-03-31 2017-03-27 改良された製剤によりアルファウイルスを安定化するための組成物及び方法

Country Status (19)

Country Link
US (2) US10632184B2 (enExample)
EP (1) EP3436063A1 (enExample)
JP (1) JP2019513138A (enExample)
KR (1) KR20180135912A (enExample)
CN (1) CN109069614A (enExample)
AU (1) AU2017241590A1 (enExample)
BR (1) BR112018069035A2 (enExample)
CA (1) CA3019529A1 (enExample)
CO (1) CO2018010357A2 (enExample)
CR (1) CR20180456A (enExample)
DO (1) DOP2018000211A (enExample)
EC (1) ECSP18081486A (enExample)
MX (1) MX2018011837A (enExample)
NI (1) NI201800096A (enExample)
PE (1) PE20190149A1 (enExample)
PH (1) PH12018502119A1 (enExample)
SG (1) SG11201808458QA (enExample)
SV (1) SV2018005747A (enExample)
WO (1) WO2017172643A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015097650A1 (en) 2013-12-23 2015-07-02 Theravectys Lyophilized lentiviral vector particles, compositions and methods
EP4010016A1 (en) * 2019-08-09 2022-06-15 Valneva SE Single shot chikungunya virus vaccine
BR112022002082A2 (pt) * 2019-08-09 2022-04-12 Valneva Se Formulações de vacina contra o chikungunya

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545555A (en) 1994-07-25 1996-08-13 Microtest, Inc. Microbial transport media
CN101516395B (zh) 2006-09-01 2014-03-26 伯哈拉特生物技术国际有限公司 抗屈曲病毒感染的疫苗
US9314519B2 (en) * 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
TWI690322B (zh) * 2012-10-02 2020-04-11 法商傳斯堅公司 含病毒的調配物及其使用
CN111729077A (zh) * 2013-03-14 2020-10-02 武田疫苗股份有限公司 减毒活甲病毒制剂的组合物和方法
CN104984357B (zh) * 2015-06-02 2018-01-30 长春百克生物科技股份公司 不含明胶的疫苗保护剂组合物及流感减毒活疫苗

Similar Documents

Publication Publication Date Title
JP2010529999A5 (enExample)
JP2017535616A5 (enExample)
JP2015525762A5 (enExample)
JP2016513069A5 (enExample)
EA201791111A1 (ru) Пероральная регидратационанная композиция и способы
JP2011088913A5 (enExample)
JP2014051497A5 (enExample)
BR112014009073A2 (pt) formulações de etanercepte estabilizadas com cloreto de sódio
HRP20200434T1 (hr) Stabilne vodene formulacije adalimumaba
JP2019513138A5 (enExample)
JP2013193968A5 (enExample)
BR112015022210A8 (pt) formulações de anticorpo
JP2012515221A5 (enExample)
JP2015134763A5 (enExample)
JP2014139241A5 (enExample)
EA201490610A1 (ru) Соединения и способы усиления врожденных иммунных ответов
JP2013508315A5 (enExample)
JP2015535237A5 (enExample)
JP2021505620A5 (enExample)
JP2015510882A5 (enExample)
JP2020517665A5 (enExample)
HRP20200196T1 (hr) Fiziološki balansirane injektabilne formulacije fosnetupitanta
JP2017019841A5 (enExample)
MX2021012968A (es) Formulaciones de anticuerpo de baja viscosidad, estables y usos de las mismas.
AR113066A1 (es) Substituto de sal baja en sodio con cloruro de potasio